(Q73407400)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11163494%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

A new approach to dose escalation in non-small-cell lung cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11163494%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11163494%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

R Scrimger

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11163494%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

R Mackie

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11163494%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

B Paliwal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11163494%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

R Chappell

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11163494%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

J Fowler

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11163494%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

language of work or name

English

0 references

publication date

1 January 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11163494%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Radiation Oncology Biology Physics

3 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11163494%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

49

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11163494%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

23-33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11163494%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11163494%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

cites work

Cancer statistics, 1999.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901374-2

7 January 2021

Combined modality treatment for stage III non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901374-2

7 January 2021

Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901374-2

7 January 2021

Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901374-2

7 January 2021

Localized adenocarcinoma of the lung: a retrospective study of 186 non-metastatic patients from the French Federation of Cancer Institutes--the Radiotherapy Cooperative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901374-2

7 January 2021

Evaluation of adjuvant postoperative radiotherapy for lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901374-2

7 January 2021

Impact of irradiation technique and tumor extent in tumor control and survival of patients with unresectable non-oat cell carcinoma of the lung. Report by the radiation therapy oncology group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901374-2

7 January 2021

Primary tumor control after radiotherapy for carcinoma of the bronchus

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901374-2

7 January 2021

Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial. CHART Steering Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901374-2

7 January 2021

Local control in medically inoperable lung cancer: an analysis of its importance in outcome and factors determining the probability of tumor eradication

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901374-2

7 January 2021

Local irradiation alone for peripheral stage I lung cancer: could we omit the elective regional nodal irradiation?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901374-2

7 January 2021

Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the Duke experience

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901374-2

7 January 2021

Impact of tumor control on survival in carcinoma of the lung treated with irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901374-2

7 January 2021

Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901374-2

7 January 2021

Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901374-2

7 January 2021

Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901374-2

7 January 2021

A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901374-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901374-2

1 reference

7 January 2021

Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901374-2

7 January 2021

Interruptions of high-dose radiation therapy decrease long-term survival of favorable patients with unresectable non-small cell carcinoma of the lung: analysis of 1244 cases from 3 Radiation Therapy Oncology Group (RTOG) trials

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901374-2

7 January 2021

Interruptions adversely affect local control and survival with hyperfractionated radiation therapy of carcinomas of the upper respiratory and digestive tracts. New evidence for accelerated proliferation from Radiation Therapy Oncology Group Protocol

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901374-2

7 January 2021

Non-small cell lung tumors repopulate rapidly during radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901374-2

7 January 2021

A modelled comparison of the effects of using different ways to compensate for missed treatment days in radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901374-2

7 January 2021

Altered fractionation trials in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901374-2

7 January 2021

Local control of oropharyngeal carcinoma after two accelerated hyperfractionation radiation therapy schemes

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901374-2

7 January 2021

Accelerated fractionation: what is the price for speeding?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901374-2

7 January 2021

The hazard of accelerated tumor clonogen repopulation during radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901374-2

7 January 2021

The linear-quadratic formula and progress in fractionated radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901374-2

7 January 2021

A realistic closed-form radiobiological model of clinical tumor-control data incorporating intertumor heterogeneity

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901374-2

7 January 2021

Time factors in larynx tumor radiotherapy: lag times and intertumor heterogeneity in clinical datasets from four centers

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901374-2

7 January 2021

Isoeffect models and fractionated radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901374-2

7 January 2021

The delay before onset of accelerated tumour cell repopulation during radiotherapy: a direct maximum-likelihood analysis of a collection of worldwide tumour-control data

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901374-2

7 January 2021

The influence of radiotherapy treatment time on the control of laryngeal cancer: a direct analysis of data from two British Institute of Radiology trials to calculate the lag period and the time factor

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901374-2

7 January 2021

The clinical significance of ratios of radiobiological parameters

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901374-2

7 January 2021

How worthwhile are short schedules in radiotherapy? A series of exploratory calculations.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901374-2

7 January 2021

Radiation pneumonitis: A new approach to the derivation of time-dose factors

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901374-2

7 January 2021

Radiation pneumonitis: experience following a large single dose of radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901374-2

7 January 2021

Idiopathic interstitial pneumonia following bone marrow transplantation: the relationship with total body irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901374-2

7 January 2021

Repair in mouse lung for up to 20 fractions of X rays or neutrons.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901374-2

7 January 2021

Acute radiation-induced pulmonary damage: a clinical study on the response to fractionated radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901374-2

7 January 2021

Radiation-induced lung damage: dose-time-fractionation considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901374-2

7 January 2021

Time-dose factors in radiotherapy: a review of the human data.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901374-2

7 January 2021

Evaluation of isoeffect formulae for predicting radiation-induced lung damage.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901374-2

7 January 2021

Radiation-induced lung damage after thoracic irradiation for Hodgkin's disease: the role of fractionation.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901374-2

7 January 2021

Injury to the lung from cancer therapy: clinical syndromes, measurable endpoints, and potential scoring systems

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901374-2

7 January 2021

Continual reassessment method: a practical design for phase 1 clinical trials in cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901374-2

7 January 2021

The continual reassessment method in cancer phase I clinical trials: a simulation study.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901374-2

7 January 2021

Practical modifications of the continual reassessment method for phase I cancer clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901374-2

7 January 2021

Repair halftimes estimated from observations of treatment-related morbidity after CHART or conventional radiotherapy in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901374-2

7 January 2021

10.1016/S0360-3016(00)01374-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11163494%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference